Daily Papers

Prognostic Health Management (PHM) systems monitor and predict equipment health. A key task is Remaining Useful Life (RUL) estimation, which predicts how long a component, such as a rolling element bearing, will operate before failure. Many RUL methods exist but often lack generalizability and robustness under changing operating conditions. This paper introduces CARLE, a hybrid AI framework that combines deep and shallow learning to address these challenges. CARLE uses Res-CNN and Res-LSTM blocks with multi-head attention and residual connections to capture spatial and temporal degradation patterns, and a Random Forest Regressor (RFR) for stable, accurate RUL prediction. A compact preprocessing pipeline applies Gaussian filtering for noise reduction and Continuous Wavelet Transform (CWT) for time-frequency feature extraction. We evaluate CARLE on the XJTU-SY and PRONOSTIA bearing datasets. Ablation studies measure each component's contribution, while noise and cross-domain experiments test robustness and generalization. Comparative results show CARLE outperforms several state-of-the-art methods, especially under dynamic conditions. Finally, we analyze model interpretability with LIME and SHAP to assess transparency and trustworthiness.

[This paper was initially published in PHME conference in 2016, selected for further publication in International Journal of Prognostics and Health Management.] This paper describes an Autoregressive Partially-hidden Markov model (ARPHMM) for fault detection and prognostics of equipments based on sensors' data. It is a particular dynamic Bayesian network that allows to represent the dynamics of a system by means of a Hidden Markov Model (HMM) and an autoregressive (AR) process. The Markov chain assumes that the system is switching back and forth between internal states while the AR process ensures a temporal coherence on sensor measurements. A sound learning procedure of standard ARHMM based on maximum likelihood allows to iteratively estimate all parameters simultaneously. This paper suggests a modification of the learning procedure considering that one may have prior knowledge about the structure which becomes partially hidden. The integration of the prior is based on the Theory of Weighted Distributions which is compatible with the Expectation-Maximization algorithm in the sense that the convergence properties are still satisfied. We show how to apply this model to estimate the remaining useful life based on health indicators. The autoregressive parameters can indeed be used for prediction while the latent structure can be used to get information about the degradation level. The interest of the proposed method for prognostics and health assessment is demonstrated on CMAPSS datasets.

Biomedical data is inherently multimodal, consisting of electronic health records, medical imaging, digital pathology, genome sequencing, wearable sensors, and more. The application of artificial intelligence tools to these multifaceted sensing technologies has the potential to revolutionize the prognosis, diagnosis, and management of human health and disease. However, current approaches to biomedical AI typically only train and evaluate with one or a small set of medical modalities and tasks. This limitation hampers the development of comprehensive tools that can leverage the rich interconnected information across many heterogeneous biomedical sensors. To address this challenge, we present MultiMed, a benchmark designed to evaluate and enable large-scale learning across a wide spectrum of medical modalities and tasks. MultiMed consists of 2.56 million samples across ten medical modalities such as medical reports, pathology, genomics, and protein data, and is structured into eleven challenging tasks, including disease prognosis, protein structure prediction, and medical question answering. Using MultiMed, we conduct comprehensive experiments benchmarking state-of-the-art unimodal, multimodal, and multitask models. Our analysis highlights the advantages of training large-scale medical models across many related modalities and tasks. Moreover, MultiMed enables studies of generalization across related medical concepts, robustness to real-world noisy data and distribution shifts, and novel modality combinations to improve prediction performance. MultiMed will be publicly available and regularly updated and welcomes inputs from the community.